Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Seminars in Cancer Biology|December 16, 2022
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccinesMariam Oladejo, Wyatt Paulishak, Laurence WoodFrontiers in Immunology|May 3, 2021
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor ImmunotherapiesMariam Oladejo, Yvonne Paterson, Laurence M WoodCancer Letters|July 27, 2023
CD105 in the progression and therapy of renal cell carcinomaMariam Oladejo, Hong-My Nguyen, Laurence WoodJournal of Controlled Release : Official Journal of the Controlled Release Society|April 3, 2024
Adjuvants in cutaneous vaccination: A comprehensive analysisMariam Oladejo, Akeemat O Tijani, Ashana Puri, et al.Breast Cancer (Tokyo, Japan)|November 18, 2022
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approachesHong-My Nguyen, Wyatt Paulishak, Mariam Oladejo, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2022
A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinomaHong-My Nguyen, Mariam Oladejo, Wyatt Paulishak, et al.Cancer Immunology, Immunotherapy : CII|December 31, 2022
Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinomaMariam Oladejo, Hong-My Nguyen, Hannah Seah, et al.Cancers|February 25, 2023
Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal CancerHong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, et al.Cancer Letters|February 3, 2023
Interferon stimulated gene 15 (ISG15) in cancer: An updateHong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, et al.Frontiers in Immunology|November 28, 2022
Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinomaMariam Oladejo, Hong-My Nguyen, Ashok Silwal, et al.Pageof 2